Page last updated: 2024-12-07

arginyl-glycyl-aspartyl-serine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

arginyl-glycyl-aspartyl-serine: corresponds to cell attachment site of fibronectin; located near carboxyl-terminal region of alpha-chain of fibrinogen; inhibits platelet aggregation & fibrinogen binding to activated platelets [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107775
CHEMBL ID265628
SCHEMBL ID7394659
MeSH IDM0134997

Synonyms (43)

Synonym
arg-gly-asp-ser, >=95% (hplc)
fibronectin tetrapeptide
l-serine, n-(n-(n-l-arginylglycyl)-l-alpha-aspartyl)-
l-serine, l-arginylglycyl-l-alpha-aspartyl-
l-arginylglycyl-l-alpha-aspartyl-l-serine
arg-gly-asp-ser
arginyl-glycyl-aspartyl-serine
rgds peptide ,
NCGC00167153-01
3-[2-(2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-(1-carboxy-2-hydroxy-ethyl)-succinamic acid (rgds)
(s)-3-[2-((s)-2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-((s)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
bdbm50241180
(s)-3-[2-((s)-2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-((r)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
rgds
3-[(s)-2-((s)-2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-(1-carboxy-2-hydroxy-ethyl)-succinamic acid
2-[1-[1-amino-4-amino(imino)methylamino-(1s)-butylcarboxamidomethylcarboxamido]-2-carboxy-(1s)-ethylcarboxamido]-3-hydroxy-(2s)-propanoic acid
2-{1-[1-amino-4-amino(imino)methylaminobutylcarboxamidomethylcarboxamido]-2-carboxyethylcarboxamido}-3-hydroxypropanoic acid
3-[2-(2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-(1-carboxy-2-hydroxy-ethyl)-succinamic acid
3-[2-((s)-2-amino-5-guanidino-pentanoylamino)-acetylamino]-n-((s)-1-carboxy-2-hydroxy-ethyl)-succinamic acid
(6s,12s,15s)-1,6-diamino-12-(carboxymethyl)-16-hydroxy-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecane-15-carboxylic acid
CHEMBL265628 ,
91037-65-9
ac6uda2mfc ,
unii-ac6uda2mfc
l-serine, l-arginylglycyl-l-.alpha.-aspartyl-
HY-12290
CS-3266
SCHEMBL7394659
(6s,12s,15s)-1,6-diamino-12-(carboxymethyl)-15-(hydroxymethyl)-1-imino-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid
AKOS024457642
mfcd00076452
DTXSID50920002
3-({2-[(2-amino-5-carbamimidamido-1-hydroxypentylidene)amino]-1-hydroxyethylidene}amino)-4-[(1-carboxy-2-hydroxyethyl)imino]-4-hydroxybutanoic acid
rgds peptide; fibronectin tetrapeptide
du-728
C77102
Q27273860
h-arg-gly-asp-ser-oh
A916494
fibronectin inhibitor
(3s)-3-[[2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-oxobutanoic acid
AS-56630
rgds peptide;fibronectin tetrapeptide

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"This study aimed to explore thrombolysis therapy based on ultrasound combined with urokinase and Arg-Gly-Asp sequence (RGDS)-targeted microbubbles by evaluating the histological changes in a thrombotic rabbit model."( A thrombolytic therapy using diagnostic ultrasound combined with RGDS-targeted microbubbles and urokinase in a rabbit model.
Guan, L; Li, Y; Liu, L; Mu, Y; Wang, C; Yan, X, 2020
)
0.56

Bioavailability

ExcerptReferenceRelevance
" Experiments with 125I-fibronectin and 125I-RGDS (Arg-Gly-Asp-Ser) demonstrated that LPS reduced both the binding of fibronectin and the bioavailability of the binding epitope on the PMN surface."( Endotoxin suppresses matrix protein-induced upregulation of PMN candicidal activity: an effect reversed by low-dose TNF-alpha.
D'Amico, R; Simms, HH, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Integrin beta-3Homo sapiens (human)IC50 (µMol)59.54880.00010.632310.0000AID1250216; AID493882; AID620659; AID73000; AID73008; AID761290; AID80179; AID84814; AID84815; AID84816; AID91595; AID92690; AID92967; AID92968; AID92971; AID93006
Integrin beta-1Homo sapiens (human)IC50 (µMol)2.20000.00010.72528.0000AID220288
Integrin alpha-IIbHomo sapiens (human)IC50 (µMol)66.19860.00010.730910.0000AID1250216; AID73000; AID73008; AID761290; AID80179; AID84814; AID84815; AID84816; AID91595; AID92690; AID92967; AID92968; AID92971; AID93006
Integrin alpha-5Homo sapiens (human)IC50 (µMol)2.20000.00011.40828.0000AID220288
Disintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)IC50 (µMol)82.00000.00021.014010.0000AID92690
Integrin betaOryctolagus cuniculus (rabbit)IC50 (µMol)5.10000.85002.97505.1000AID1250216
Glycoprotein IIbOryctolagus cuniculus (rabbit)IC50 (µMol)5.10000.85002.97505.1000AID1250216
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (207)

Processvia Protein(s)Taxonomy
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayIntegrin beta-1Homo sapiens (human)
stress fiber assemblyIntegrin beta-1Homo sapiens (human)
calcium-independent cell-matrix adhesionIntegrin beta-1Homo sapiens (human)
positive regulation of apoptotic processIntegrin beta-1Homo sapiens (human)
positive regulation of glutamate uptake involved in transmission of nerve impulseIntegrin beta-1Homo sapiens (human)
regulation of inward rectifier potassium channel activityIntegrin beta-1Homo sapiens (human)
regulation of spontaneous synaptic transmissionIntegrin beta-1Homo sapiens (human)
reactive gliosisIntegrin beta-1Homo sapiens (human)
G1/S transition of mitotic cell cycleIntegrin beta-1Homo sapiens (human)
establishment of mitotic spindle orientationIntegrin beta-1Homo sapiens (human)
in utero embryonic developmentIntegrin beta-1Homo sapiens (human)
cell migration involved in sprouting angiogenesisIntegrin beta-1Homo sapiens (human)
positive regulation of neuroblast proliferationIntegrin beta-1Homo sapiens (human)
phagocytosisIntegrin beta-1Homo sapiens (human)
cellular defense responseIntegrin beta-1Homo sapiens (human)
cell adhesionIntegrin beta-1Homo sapiens (human)
homophilic cell adhesion via plasma membrane adhesion moleculesIntegrin beta-1Homo sapiens (human)
leukocyte cell-cell adhesionIntegrin beta-1Homo sapiens (human)
cell-matrix adhesionIntegrin beta-1Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-1Homo sapiens (human)
neuroblast proliferationIntegrin beta-1Homo sapiens (human)
muscle organ developmentIntegrin beta-1Homo sapiens (human)
myoblast fusionIntegrin beta-1Homo sapiens (human)
germ cell migrationIntegrin beta-1Homo sapiens (human)
visual learningIntegrin beta-1Homo sapiens (human)
regulation of collagen catabolic processIntegrin beta-1Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-1Homo sapiens (human)
cell migrationIntegrin beta-1Homo sapiens (human)
formation of radial glial scaffoldsIntegrin beta-1Homo sapiens (human)
CD40 signaling pathwayIntegrin beta-1Homo sapiens (human)
cell projection organizationIntegrin beta-1Homo sapiens (human)
lamellipodium assemblyIntegrin beta-1Homo sapiens (human)
B cell differentiationIntegrin beta-1Homo sapiens (human)
extracellular matrix organizationIntegrin beta-1Homo sapiens (human)
positive regulation of cell migrationIntegrin beta-1Homo sapiens (human)
cell-substrate adhesionIntegrin beta-1Homo sapiens (human)
receptor internalizationIntegrin beta-1Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-1Homo sapiens (human)
cell-cell adhesion mediated by integrinIntegrin beta-1Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-1Homo sapiens (human)
negative regulation of Rho protein signal transductionIntegrin beta-1Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-1Homo sapiens (human)
maintenance of blood-brain barrierIntegrin beta-1Homo sapiens (human)
positive regulation of GTPase activityIntegrin beta-1Homo sapiens (human)
sarcomere organizationIntegrin beta-1Homo sapiens (human)
myoblast differentiationIntegrin beta-1Homo sapiens (human)
negative regulation of neuron differentiationIntegrin beta-1Homo sapiens (human)
positive regulation of fibroblast growth factor receptor signaling pathwayIntegrin beta-1Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-1Homo sapiens (human)
negative regulation of vasoconstrictionIntegrin beta-1Homo sapiens (human)
symbiont entry into host cellIntegrin beta-1Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-1Homo sapiens (human)
myoblast fate specificationIntegrin beta-1Homo sapiens (human)
axon extensionIntegrin beta-1Homo sapiens (human)
dendrite morphogenesisIntegrin beta-1Homo sapiens (human)
leukocyte tethering or rollingIntegrin beta-1Homo sapiens (human)
regulation of cell cycleIntegrin beta-1Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionIntegrin beta-1Homo sapiens (human)
cardiac muscle cell differentiationIntegrin beta-1Homo sapiens (human)
cardiac muscle cell myoblast differentiationIntegrin beta-1Homo sapiens (human)
cardiac cell fate specificationIntegrin beta-1Homo sapiens (human)
cellular response to low-density lipoprotein particle stimulusIntegrin beta-1Homo sapiens (human)
basement membrane organizationIntegrin beta-1Homo sapiens (human)
positive regulation of wound healingIntegrin beta-1Homo sapiens (human)
positive regulation of vascular endothelial growth factor signaling pathwayIntegrin beta-1Homo sapiens (human)
positive regulation of protein localization to plasma membraneIntegrin beta-1Homo sapiens (human)
regulation of synapse pruningIntegrin beta-1Homo sapiens (human)
negative regulation of anoikisIntegrin beta-1Homo sapiens (human)
cell-cell adhesionIntegrin beta-1Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-5Homo sapiens (human)
cell-substrate junction assemblyIntegrin alpha-5Homo sapiens (human)
cell adhesionIntegrin alpha-5Homo sapiens (human)
heterophilic cell-cell adhesion via plasma membrane cell adhesion moleculesIntegrin alpha-5Homo sapiens (human)
leukocyte cell-cell adhesionIntegrin alpha-5Homo sapiens (human)
cell-matrix adhesionIntegrin alpha-5Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-5Homo sapiens (human)
female pregnancyIntegrin alpha-5Homo sapiens (human)
memoryIntegrin alpha-5Homo sapiens (human)
positive regulation of cell-substrate adhesionIntegrin alpha-5Homo sapiens (human)
CD40 signaling pathwayIntegrin alpha-5Homo sapiens (human)
positive regulation of cell migrationIntegrin alpha-5Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin alpha-5Homo sapiens (human)
cell-substrate adhesionIntegrin alpha-5Homo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-5Homo sapiens (human)
cell-cell adhesion mediated by integrinIntegrin alpha-5Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin alpha-5Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin alpha-5Homo sapiens (human)
endodermal cell differentiationIntegrin alpha-5Homo sapiens (human)
symbiont entry into host cellIntegrin alpha-5Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin alpha-5Homo sapiens (human)
positive regulation of sprouting angiogenesisIntegrin alpha-5Homo sapiens (human)
negative regulation of anoikisIntegrin alpha-5Homo sapiens (human)
cell-cell adhesionIntegrin alpha-5Homo sapiens (human)
response to hypoxiaIntegrin alpha-2Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-2Homo sapiens (human)
substrate-dependent cell migrationIntegrin alpha-2Homo sapiens (human)
hypotonic responseIntegrin alpha-2Homo sapiens (human)
cell adhesionIntegrin alpha-2Homo sapiens (human)
cell-matrix adhesionIntegrin alpha-2Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-2Homo sapiens (human)
female pregnancyIntegrin alpha-2Homo sapiens (human)
blood coagulationIntegrin alpha-2Homo sapiens (human)
response to xenobiotic stimulusIntegrin alpha-2Homo sapiens (human)
animal organ morphogenesisIntegrin alpha-2Homo sapiens (human)
positive regulation of epithelial cell migrationIntegrin alpha-2Homo sapiens (human)
response to amineIntegrin alpha-2Homo sapiens (human)
response to muscle activityIntegrin alpha-2Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin alpha-2Homo sapiens (human)
extracellular matrix organizationIntegrin alpha-2Homo sapiens (human)
mammary gland developmentIntegrin alpha-2Homo sapiens (human)
positive regulation of cell projection organizationIntegrin alpha-2Homo sapiens (human)
cell-substrate adhesionIntegrin alpha-2Homo sapiens (human)
positive regulation of collagen biosynthetic processIntegrin alpha-2Homo sapiens (human)
response to L-ascorbic acidIntegrin alpha-2Homo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-2Homo sapiens (human)
collagen-activated signaling pathwayIntegrin alpha-2Homo sapiens (human)
skin morphogenesisIntegrin alpha-2Homo sapiens (human)
positive regulation of translationIntegrin alpha-2Homo sapiens (human)
positive regulation of cell adhesionIntegrin alpha-2Homo sapiens (human)
positive regulation of smooth muscle contractionIntegrin alpha-2Homo sapiens (human)
symbiont entry into host cellIntegrin alpha-2Homo sapiens (human)
focal adhesion assemblyIntegrin alpha-2Homo sapiens (human)
mesodermal cell differentiationIntegrin alpha-2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin alpha-2Homo sapiens (human)
positive regulation of positive chemotaxisIntegrin alpha-2Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painIntegrin alpha-2Homo sapiens (human)
positive regulation of transmission of nerve impulseIntegrin alpha-2Homo sapiens (human)
positive regulation of phagocytosis, engulfmentIntegrin alpha-2Homo sapiens (human)
hepatocyte differentiationIntegrin alpha-2Homo sapiens (human)
response to parathyroid hormoneIntegrin alpha-2Homo sapiens (human)
cellular response to mechanical stimulusIntegrin alpha-2Homo sapiens (human)
cellular response to estradiol stimulusIntegrin alpha-2Homo sapiens (human)
cell-cell adhesionIntegrin alpha-2Homo sapiens (human)
negative regulation of Rho protein signal transductionIntegrin alpha-3Homo sapiens (human)
exploration behaviorIntegrin alpha-3Homo sapiens (human)
dendritic spine maintenanceIntegrin alpha-3Homo sapiens (human)
neuron migrationIntegrin alpha-3Homo sapiens (human)
Rho protein signal transductionIntegrin alpha-3Homo sapiens (human)
heart developmentIntegrin alpha-3Homo sapiens (human)
memoryIntegrin alpha-3Homo sapiens (human)
response to xenobiotic stimulusIntegrin alpha-3Homo sapiens (human)
positive regulation of gene expressionIntegrin alpha-3Homo sapiens (human)
positive regulation of epithelial cell migrationIntegrin alpha-3Homo sapiens (human)
positive regulation of cell-substrate adhesionIntegrin alpha-3Homo sapiens (human)
positive regulation of neuron projection developmentIntegrin alpha-3Homo sapiens (human)
regulation of transforming growth factor beta receptor signaling pathwayIntegrin alpha-3Homo sapiens (human)
regulation of Wnt signaling pathwayIntegrin alpha-3Homo sapiens (human)
lung developmentIntegrin alpha-3Homo sapiens (human)
regulation of BMP signaling pathwayIntegrin alpha-3Homo sapiens (human)
negative regulation of cell projection organizationIntegrin alpha-3Homo sapiens (human)
response to gonadotropinIntegrin alpha-3Homo sapiens (human)
skin developmentIntegrin alpha-3Homo sapiens (human)
mesodermal cell differentiationIntegrin alpha-3Homo sapiens (human)
maternal process involved in female pregnancyIntegrin alpha-3Homo sapiens (human)
nephron developmentIntegrin alpha-3Homo sapiens (human)
renal filtrationIntegrin alpha-3Homo sapiens (human)
synaptic membrane adhesionIntegrin alpha-3Homo sapiens (human)
positive regulation of protein localization to plasma membraneIntegrin alpha-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-3Homo sapiens (human)
cell-cell adhesionIntegrin alpha-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-3Homo sapiens (human)
cell-matrix adhesionIntegrin alpha-3Homo sapiens (human)
leukocyte migrationIntegrin alpha-3Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to hypoxiaDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
neutrophil mediated immunityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
germinal center formationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of leukocyte chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane protein ectodomain proteolysisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch receptor processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell population proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to xenobiotic stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of T cell chemotaxisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein processingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
signal releaseDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
B cell differentiationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell growthDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
response to lipopolysaccharideDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of chemokine productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor productionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
regulation of mast cell apoptotic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
T cell differentiation in thymusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell adhesion mediated by integrinDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
wound healing, spreading of epidermal cellsDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of blood vessel endothelial cell migrationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor-activated receptor activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of epidermal growth factor receptor signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
spleen developmentDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell motilityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
defense response to Gram-positive bacteriumDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cellular response to high density lipoprotein particle stimulusDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
commissural neuron axon guidanceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
negative regulation of cold-induced thermogenesisDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of tumor necrosis factor-mediated signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
positive regulation of vascular endothelial cell proliferationDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch signaling pathwayDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (49)

Processvia Protein(s)Taxonomy
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-1Homo sapiens (human)
magnesium ion bindingIntegrin beta-1Homo sapiens (human)
virus receptor activityIntegrin beta-1Homo sapiens (human)
fibronectin bindingIntegrin beta-1Homo sapiens (human)
protease bindingIntegrin beta-1Homo sapiens (human)
actin bindingIntegrin beta-1Homo sapiens (human)
integrin bindingIntegrin beta-1Homo sapiens (human)
calcium ion bindingIntegrin beta-1Homo sapiens (human)
protein bindingIntegrin beta-1Homo sapiens (human)
coreceptor activityIntegrin beta-1Homo sapiens (human)
protein-containing complex bindingIntegrin beta-1Homo sapiens (human)
cadherin bindingIntegrin beta-1Homo sapiens (human)
protein heterodimerization activityIntegrin beta-1Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-1Homo sapiens (human)
collagen binding involved in cell-matrix adhesionIntegrin beta-1Homo sapiens (human)
integrin binding involved in cell-matrix adhesionIntegrin beta-1Homo sapiens (human)
protein tyrosine kinase bindingIntegrin beta-1Homo sapiens (human)
protein kinase bindingIntegrin beta-1Homo sapiens (human)
laminin bindingIntegrin beta-1Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
virus receptor activityIntegrin alpha-5Homo sapiens (human)
epidermal growth factor receptor bindingIntegrin alpha-5Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin alpha-5Homo sapiens (human)
calcium ion bindingIntegrin alpha-5Homo sapiens (human)
protein bindingIntegrin alpha-5Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin alpha-5Homo sapiens (human)
integrin bindingIntegrin alpha-5Homo sapiens (human)
amyloid-beta bindingIntegrin alpha-2Homo sapiens (human)
virus receptor activityIntegrin alpha-2Homo sapiens (human)
protein bindingIntegrin alpha-2Homo sapiens (human)
collagen bindingIntegrin alpha-2Homo sapiens (human)
collagen receptor activityIntegrin alpha-2Homo sapiens (human)
laminin bindingIntegrin alpha-2Homo sapiens (human)
heparan sulfate proteoglycan bindingIntegrin alpha-2Homo sapiens (human)
protein-containing complex bindingIntegrin alpha-2Homo sapiens (human)
metal ion bindingIntegrin alpha-2Homo sapiens (human)
collagen binding involved in cell-matrix adhesionIntegrin alpha-2Homo sapiens (human)
integrin bindingIntegrin alpha-2Homo sapiens (human)
fibronectin bindingIntegrin alpha-3Homo sapiens (human)
protease bindingIntegrin alpha-3Homo sapiens (human)
protein bindingIntegrin alpha-3Homo sapiens (human)
collagen bindingIntegrin alpha-3Homo sapiens (human)
protein domain specific bindingIntegrin alpha-3Homo sapiens (human)
laminin bindingIntegrin alpha-3Homo sapiens (human)
metal ion bindingIntegrin alpha-3Homo sapiens (human)
protein heterodimerization activityIntegrin alpha-3Homo sapiens (human)
integrin bindingIntegrin alpha-3Homo sapiens (human)
endopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Notch bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
interleukin-6 receptor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
integrin bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
protein bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
peptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metallopeptidase activityDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
SH3 domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytokine bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
PDZ domain bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
tumor necrosis factor bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metal ion bindingDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
metalloendopeptidase activity involved in amyloid precursor protein catabolic processDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (75)

Processvia Protein(s)Taxonomy
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-1Homo sapiens (human)
ruffle membraneIntegrin beta-1Homo sapiens (human)
ruffleIntegrin beta-1Homo sapiens (human)
cytoplasmIntegrin beta-1Homo sapiens (human)
plasma membraneIntegrin beta-1Homo sapiens (human)
focal adhesionIntegrin beta-1Homo sapiens (human)
external side of plasma membraneIntegrin beta-1Homo sapiens (human)
cell surfaceIntegrin beta-1Homo sapiens (human)
endosome membraneIntegrin beta-1Homo sapiens (human)
intercalated discIntegrin beta-1Homo sapiens (human)
membraneIntegrin beta-1Homo sapiens (human)
lamellipodiumIntegrin beta-1Homo sapiens (human)
filopodiumIntegrin beta-1Homo sapiens (human)
neuromuscular junctionIntegrin beta-1Homo sapiens (human)
cleavage furrowIntegrin beta-1Homo sapiens (human)
ruffle membraneIntegrin beta-1Homo sapiens (human)
integrin alpha1-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha2-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha4-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha5-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha6-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha9-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha10-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alphav-beta1 complexIntegrin beta-1Homo sapiens (human)
myelin sheath abaxonal regionIntegrin beta-1Homo sapiens (human)
sarcolemmaIntegrin beta-1Homo sapiens (human)
melanosomeIntegrin beta-1Homo sapiens (human)
dendritic spineIntegrin beta-1Homo sapiens (human)
membrane raftIntegrin beta-1Homo sapiens (human)
perinuclear region of cytoplasmIntegrin beta-1Homo sapiens (human)
recycling endosomeIntegrin beta-1Homo sapiens (human)
extracellular exosomeIntegrin beta-1Homo sapiens (human)
synaptic membraneIntegrin beta-1Homo sapiens (human)
glial cell projectionIntegrin beta-1Homo sapiens (human)
Schaffer collateral - CA1 synapseIntegrin beta-1Homo sapiens (human)
cerebellar climbing fiber to Purkinje cell synapseIntegrin beta-1Homo sapiens (human)
integrin alpha3-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha7-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha8-beta1 complexIntegrin beta-1Homo sapiens (human)
integrin alpha11-beta1 complexIntegrin beta-1Homo sapiens (human)
receptor complexIntegrin beta-1Homo sapiens (human)
focal adhesionIntegrin beta-1Homo sapiens (human)
synapseIntegrin beta-1Homo sapiens (human)
integrin complexIntegrin beta-1Homo sapiens (human)
cell surfaceIntegrin beta-1Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
cell-cell junctionIntegrin alpha-5Homo sapiens (human)
focal adhesionIntegrin alpha-5Homo sapiens (human)
ruffle membraneIntegrin alpha-5Homo sapiens (human)
ruffleIntegrin alpha-5Homo sapiens (human)
endoplasmic reticulumIntegrin alpha-5Homo sapiens (human)
Golgi apparatusIntegrin alpha-5Homo sapiens (human)
plasma membraneIntegrin alpha-5Homo sapiens (human)
focal adhesionIntegrin alpha-5Homo sapiens (human)
cell surfaceIntegrin alpha-5Homo sapiens (human)
cytoplasmic vesicleIntegrin alpha-5Homo sapiens (human)
integrin alpha5-beta1 complexIntegrin alpha-5Homo sapiens (human)
postsynaptic membraneIntegrin alpha-5Homo sapiens (human)
glutamatergic synapseIntegrin alpha-5Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin alpha-5Homo sapiens (human)
external side of plasma membraneIntegrin alpha-5Homo sapiens (human)
integrin complexIntegrin alpha-5Homo sapiens (human)
plasma membraneIntegrin alpha-2Homo sapiens (human)
focal adhesionIntegrin alpha-2Homo sapiens (human)
cell surfaceIntegrin alpha-2Homo sapiens (human)
integrin alpha2-beta1 complexIntegrin alpha-2Homo sapiens (human)
axon terminusIntegrin alpha-2Homo sapiens (human)
basal part of cellIntegrin alpha-2Homo sapiens (human)
perinuclear region of cytoplasmIntegrin alpha-2Homo sapiens (human)
integrin complexIntegrin alpha-2Homo sapiens (human)
external side of plasma membraneIntegrin alpha-2Homo sapiens (human)
plasma membraneIntegrin alpha-3Homo sapiens (human)
focal adhesionIntegrin alpha-3Homo sapiens (human)
cell surfaceIntegrin alpha-3Homo sapiens (human)
basolateral plasma membraneIntegrin alpha-3Homo sapiens (human)
filopodium membraneIntegrin alpha-3Homo sapiens (human)
neuromuscular junctionIntegrin alpha-3Homo sapiens (human)
postsynaptic membraneIntegrin alpha-3Homo sapiens (human)
perinuclear region of cytoplasmIntegrin alpha-3Homo sapiens (human)
presynaptic active zone membraneIntegrin alpha-3Homo sapiens (human)
excitatory synapseIntegrin alpha-3Homo sapiens (human)
extracellular exosomeIntegrin alpha-3Homo sapiens (human)
cell peripheryIntegrin alpha-3Homo sapiens (human)
synaptic membraneIntegrin alpha-3Homo sapiens (human)
glutamatergic synapseIntegrin alpha-3Homo sapiens (human)
growth cone filopodiumIntegrin alpha-3Homo sapiens (human)
integrin alpha3-beta1 complexIntegrin alpha-3Homo sapiens (human)
receptor complexIntegrin alpha-3Homo sapiens (human)
external side of plasma membraneIntegrin alpha-3Homo sapiens (human)
integrin complexIntegrin alpha-3Homo sapiens (human)
cell-cell junctionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
focal adhesionDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
ruffle membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
Golgi membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytoplasmDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
endoplasmic reticulum lumenDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cytosolDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
cell surfaceDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
actin cytoskeletonDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
apical plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
membrane raftDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
plasma membraneDisintegrin and metalloproteinase domain-containing protein 17Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (90)

Assay IDTitleYearJournalArticle
AID165511Tested in vitro for the maximal rate of platelet aggregation induced by platelet activating factor (10 e-7 mol/L) at a dose of 10 e5 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID165505Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-5 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID84814Inhibition of HUVEC adhesion to fibrinogen-coated plates1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Design of a new class of orally active fibrinogen receptor antagonists.
AID190472Tested for the effect on the dry thrombus weight at a dose of 5 umol/kg in male wistar anesthetized rat2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID381996Inhibition of 1 uM platelet activating factor-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID26921Association constant of compound against selectin E was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID80179Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of guinea pig platelets by 50% in vitro1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
AID170332Effect on the dry thrombus weight in male wistar rat was determined(in vivo)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID381993Inhibition of 1 uM adenosine diphosphate-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID93006In vitro inhibition of ADP-mediated human gel filtered platelet aggregation.1992Journal of medicinal chemistry, Nov-27, Volume: 35, Issue:24
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
AID165506Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-6 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID291683Effect on dry weight of femurs in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID381992Inhibition of 10 uM adenosine diphosphate-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID202743Binding affinity of compound against selectin P was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID381983Nitric oxide radical scavenging activity in rat aortic strip assessed as inhibition of acetylcholine-induced vasorelaxation at 1 uM2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID381994Inhibition of 0.1 uM adenosine diphosphate-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID223376Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by collagen1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID291681Effect on serum calcium level in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID165502Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-5 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID73008Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia (HEL) cells.1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
AID92968Inhibition of collagen-induced platelet aggregation1995Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.
AID620660Inhibition of ADP-induced platelet aggregation in human platelet rich plasma by Borns method2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
AID91595Inhibition of integrin alphaIIb-beta3 binding2001Journal of medicinal chemistry, Sep-13, Volume: 44, Issue:19
Determination of the binding specificity of an integral membrane protein by saturation transfer difference NMR: RGD peptide ligands binding to integrin alphaIIbbeta3.
AID27152Dissociation constant of compound against selectin L was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID92219Inhibition of human platelet (isolated from PRP) aggregation2001Journal of medicinal chemistry, Apr-12, Volume: 44, Issue:8
Discovery of an orally active non-peptide fibrinogen receptor antagonist based on the hydantoin scaffold.
AID291686Effect on calcium level in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID217303Inhibition of fibrinogen binding to immobilized vitronectin receptor1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID158247Inhibitory activity against aggregation of human platelets1996Journal of medicinal chemistry, May-24, Volume: 39, Issue:11
Discovery of an orally active non-peptide fibrinogen receptor antagonist.
AID291689Effect on lung weight in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID761291Inhibition of ADP-induced human platelet aggregation in platelet-rich plasma by Born's method2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Synthesis, biological evaluation, X-ray molecular structure and molecular docking studies of RGD mimetics containing 6-amino-2,3-dihydroisoindolin-1-one fragment as ligands of integrin αIIbβ₃.
AID270581Effect on ADP-induced platelet aggregation in rabbit platelet-rich plasma at 10 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID270582Effect on ADP-induced platelet aggregation in rabbit platelet-rich plasma at 1 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID270586Effect on PAF-induced platelet aggregation in rabbit platelet-rich plasma at 0.1 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID92969In vitro inhibition of thrombin-induced platelet aggregation.1995Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.
AID270585Effect on PAF-induced platelet aggregation in rabbit platelet-rich plasma at 1 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID165512Tested in vitro for the maximal rate of platelet aggregation induced by platelet activating factor (10 e-7 mol/L) at a dose of 10 e6 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID1372017Inhibition of GP2b/3a in rat platelet-rich plasma assessed as reduction in arachidonic acid-induced platelet aggregation at 10'-8 to 10'-2 M after 5 mins by aggregometric analysis2017Bioorganic & medicinal chemistry letters, 12-01, Volume: 27, Issue:23
Docking based design of diastereoisomeric MTCA as GPIIb/IIIa receptor inhibitor.
AID165509Tested in vitro for maximal rate of platelet aggregation induced by adenosine diphosphate (10 e5 mol/L) at a dose of 10 e6 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID92830Compound was tested for its ability to inhibit the thrombin-induced platelet aggregation in washed human platelets1998Bioorganic & medicinal chemistry letters, Oct-06, Volume: 8, Issue:19
Tropane-based amino acids for peptide structure-function studies: inhibitors of platelet aggregation.
AID92690Ability to inhibit the aggregation of fixed human platelets1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Design of a new class of orally active fibrinogen receptor antagonists.
AID202556Binding affinity of compound against selectin E was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID26922Association constant of compound against selectin L was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID73000Inhibition of [125I]fibrinogen binding to human Fibrinogen Receptor.1995Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.
AID291690Effect on liver weight in ovariectomized mouse at 0.110 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID202715Binding affinity of compound against selectin L was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID183997Compound tested for inhibition of Ach-induced vasorelaxation was determined in rat aortic strips2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID381995Inhibition of 10 uM platelet activating factor-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID220288Inhibition of fibronectin (GST-3Fn8-11) binding to recombinant soluble mini integrin alpha5-beta12003Bioorganic & medicinal chemistry letters, May-05, Volume: 13, Issue:9
Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam.
AID270584Effect on PAF-induced platelet aggregation in rabbit platelet-rich plasma at 10 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID165508Tested in vitro for maximal rate of platelet aggregation induced by adenosine diphosphate (10 e5 mol/L) at a dose of 10 e5 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID165510Tested in vitro for maximal rate of platelet aggregation induced by adenosine diphosphate (10 e5 mol/L) at a dose of 10 e7 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID170337Effect on the wet thrombus weight in male wistar rat was determined(in vivo)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID291679Increase in body weight in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID223375Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by adenosine 5'-diphosphate-(ADP)1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID291688Effect on mineral content in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID270583Effect on ADP-induced platelet aggregation in rabbit platelet-rich plasma at 0.1 uM2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID291684Effect on femur ash weight in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID84815Inhibition of HUVEC adhesion to fibrinogen-coated plates1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Design of a new class of orally active fibrinogen receptor antagonists.
AID291685Effect on femur length in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID761290Inhibition of FITC-labeled fibrinogen binding to integrin alpha2bbeta3 receptor in human platelets by flow cytometry2013Bioorganic & medicinal chemistry, Aug-01, Volume: 21, Issue:15
Synthesis, biological evaluation, X-ray molecular structure and molecular docking studies of RGD mimetics containing 6-amino-2,3-dihydroisoindolin-1-one fragment as ligands of integrin αIIbβ₃.
AID73164Inhibition of fibrinogen binding to immobilized fibrinogen receptor1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID291680Effect on serum ALP lavel in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID165513Tested in vitro for the maximal rate of platelet aggregation induced by platelet activating factor (10 e-7 mol/L) at a dose of 10 e7 mol/L in rabbit blood2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID291691Effect on spleen weight in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID223377Inhibition of platelet aggregation in human-platelet rich plasma(h-PRP) induced by thrombin1992Journal of medicinal chemistry, Nov-13, Volume: 35, Issue:23
Low molecular weight, non-peptide fibrinogen receptor antagonists.
AID382001Antithrombotic activity in Wistar rat assessed as wet thrombus weight at 5 umol/kg2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID270588Decrease in weight of dry thrombus in rat at 5 umol/kg2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID291682Effect on serum phosphorus level in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID200412Tested for the effect of compound on the adhesion of high pulmonary metastatic SACC cell line SACC-LM and platelets at 5 mg/mL2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID493881Antagonist activity at FITC-tagged alpha3beta3 integrin in human platelet rich plasma2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
AID26923Association constant of compound against selectin P was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID291692Effect on uterus weight in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID620659Displacement of FITC-labeled fibrinogen from alpha2beta3 in human platelets2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.
AID381999Antithrombotic activity in Wistar rat assessed as wet thrombus weight at 5 umol/kg2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID382240Nitric oxide radical scavenging activity in rat aortic strip assessed as inhibition of acetylcholine-induced vasorelaxation at 10 uM2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID291687Effect on phosphorus level in ovariectomized mouse at 0.1103 mmol/kg, ip once daily for 4 weeks2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Improved anti-osteoporosis potency and reduced endometrial membrane hyperplasia during hormone replacement therapy with estrogen-RGD peptide conjugates.
AID27151Dissociation constant of compound against selectin E was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID165503Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-6 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID270587Decrease in weight of wet thrombus in rat at 5 umol/kg2006Bioorganic & medicinal chemistry letters, Sep-01, Volume: 16, Issue:17
Dual-acting agents that possess free radical scavenging and antithrombotic activities: design, synthesis, and evaluation of phenolic tetrahydro-beta-carboline RGD peptide conjugates.
AID27153Dissociation constant of compound against selectin P was determined2001Journal of medicinal chemistry, Mar-01, Volume: 44, Issue:5
Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
AID381984Nitric oxide radical scavenging activity in rat aortic strip assessed as inhibition of acetylcholine-induced vasorelaxation at 100 uM2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID190475Tested for the effect on the wet thrombus weight at a dose of 5 umol/kg in male wistar anesthetized rat2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
Synthesis and antithrombotic activity of carbolinecarboxyl RGD sequence.
AID165504Maximum rate of ADP induced platelet aggregation was determined in rabbit blood at a dose of 10-7 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID493882Antagonist activity at FITC-tagged alpha3beta3 integrin in human platelet assessed as reduction of ADP-induced platelet aggregation2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.
AID381997Inhibition of 0.1 uM platelet activating factor-induced platelet aggregation in rabbit blood2008Bioorganic & medicinal chemistry, Apr-01, Volume: 16, Issue:7
A class of novel nitronyl nitroxide labeling basic and acidic amino acids: synthesis, application for preparing ESR optionally labeling peptides, and bioactivity investigations.
AID1250216Antagonist activity at GP2b/3a receptor (unknown origin) assessed as inhibition of interaction with fibrinogen after 2 hrs by ELISA2015European journal of medicinal chemistry, Sep-18, Volume: 102Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
AID84816Inhibition of HUVEC adhesion to fibrinogen-coated plates1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Design of a new class of orally active fibrinogen receptor antagonists.
AID165507Maximum rate of PAF induced platelet aggregation was determined in rabbit blood at a dose of 10-7 mol/L (in vitro)2003Bioorganic & medicinal chemistry letters, Nov-17, Volume: 13, Issue:22
Synthesis and bioactivities of nitronyl nitroxide and RGD containing pseudopeptides.
AID92967Inhibition of arachidonic acid-induced platelet aggregation1995Journal of medicinal chemistry, Jan-06, Volume: 38, Issue:1
Novel thiazole-based heterocycles as selective inhibitors of fibrinogen-mediated platelet aggregation.
AID92971Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.1998Journal of medicinal chemistry, Feb-12, Volume: 41, Issue:4
Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (483)

TimeframeStudies, This Drug (%)All Drugs %
pre-199041 (8.49)18.7374
1990's224 (46.38)18.2507
2000's125 (25.88)29.6817
2010's84 (17.39)24.3611
2020's9 (1.86)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 8.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index8.79 (24.57)
Research Supply Index6.22 (2.92)
Research Growth Index5.01 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (8.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews10 (1.99%)6.00%
Case Studies2 (0.40%)4.05%
Observational0 (0.00%)0.25%
Other491 (97.61%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]